Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases
Boulos Mansour1, Tomas Vanecek2, Liubov Kastnerova2
1Department of Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.
Abstract:
Spitz tumors are melanocytic neoplasms characterized by specific, mutually exclusive driver molecular events, namely genomic rearrangements involving the threonine kinase BRAF and the tyrosine kinase receptors ALK , NTRK1 , NTRK2 , NTRK3 , MET , RET , ROS1 , and MAP3K8 or less commonly, mutations in HRAS or MAP2K1 . We hereby report 5 Spitz tumors with a SQSTM1::NTRK2 fusion. All patients were woman with the ages at diagnosis ranging from 30 to 50 years. Locations included the lower extremity (n = 3), forearm, and back (one each). All the neoplasms were superficial melanocytic proliferation with a flat to dome-shaped silhouette, in which junctional spindled and polygonal dendritic melanocytes were mainly arranged as horizontal nests associated with conspicuous lentiginous involvement of the follicular epithelium. Only one case showed heavily pigmented, vertically oriented melanocytic nests resembling Reed nevus. A superficial intradermal component observed in 2 cases appeared as small nests with a back-to-back configuration. In all lesions, next-generation sequencing analysis identified a SQSTM1::NTRK2 fusion. A single case studied with fluorescence in situ hybridization for copy number changes in melanoma-related genes proved negative. No further molecular alterations were detected, including TERT-p hotspot mutations.
Insights
This study identifies a novel SQSTM1::NTRK2 gene fusion in five Spitz tumors, a rare type of melanocytic neoplasm. This finding advances understanding of the molecular drivers in Spitz tumor development.
Area of Science:
- Dermatopathology
- Molecular Oncology
- Genetics
Background:
- Spitz tumors are melanocytic neoplasms defined by specific molecular alterations.
- Known driver events include rearrangements of BRAF, ALK, NTRK, MET, RET, ROS1, MAP3K8, or mutations in HRAS/MAP2K1.
Purpose of the Study:
- To report and characterize Spitz tumors harboring a SQSTM1::NTRK2 fusion.
- To investigate the clinicopathological and molecular features of these rare neoplasms.
Main Methods:
- Histopathological examination of five Spitz tumors.
- Next-generation sequencing (NGS) for molecular analysis.
- Fluorescence in situ hybridization (FISH) in one case.
Main Results:
- Five cases of Spitz tumors with a SQSTM1::NTRK2 fusion were identified.
- Patients were women aged 30-50, with tumors on the lower extremity, forearm, and back.
- Histopathology revealed superficial melanocytic proliferation with specific nesting patterns; one case resembled Reed nevus.
Conclusions:
- The SQSTM1::NTRK2 fusion is a newly identified molecular event in Spitz tumors.
- This fusion represents a potential driver alteration in a subset of these melanocytic neoplasms.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021